Has Karen Bell, MD received payments from drug or device companies?

Yes. Drug and device makers reported $17,908 in general payments to Karen Bell, MD across 13 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Karen Bell, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Karen Bell, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Karen Bell, MD

Neurology · New York, NYNPI 1164450318

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $17,500 of the $17,908 with a category attached, or 97.7%. Eli Lilly accounts for 97.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2023 at $17,606 and has fallen 98.9% since, to $186 in 2025.

$17,908in general payments, 2019–2025

Across 13 payments — averaging $1377.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Eli Lilly$18K
Eisai Inc.$146
AbbVie$116
Progenics Pharmaceuticals, Inc.$106
Johnson & Johnson$40

$503,754in research payments, 2019–2025

Across 44 payments — averaging $11,449 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eisai Inc.$253K
Eli Lilly$212K
Biohaven Pharmaceutical Holding Company Ltd.$39K

What the payments were for

Consulting fees$17,50098%
Food & beverage$4082%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Eli Lilly	8	$17,500
Eisai Inc.	2	$146
AbbVie	1	$116
Progenics Pharmaceuticals, Inc.	1	$106
Johnson & Johnson	1	$40

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Leqembi$125
PYLARIFY$106

How this compares

$17,908 in reported general payments places this provider in the 80th percentile of 1,623 neurology providers in New York.

See all neurology providers in New York →

Medicare billing

Part B allowed, 2024

$87,199

Medicare patients

367

Services billed

746

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Memantine Hcl ErMemantine Hcl	146	$17,607
Galantamine ErGalantamine Hbr	177	$15,063
Rivastigmine	72	$14,463
Donepezil Hcl	360	$3,724
Memantine Hcl	54	$1,759
Quetiapine Fumarate	116	$1,198
Escitalopram Oxalate	88	$1,161
Mirtazapine	15	$885
Sertraline Hcl	21	$223
Risperidone	14	$184
Trazodone Hcl	14	$91
Lorazepam	15	$57

Paid to pharmacies, not to this prescriber.

Other neurology in New York

Stephen KriegerNew York$1.1M
Sheng-Han KuoNew York$657K
Timothy VartanianNew York$468K
Steven WolfNew York$428K
David DodickNew York$426K
David SimpsonNew York$403K
Fred LublinNew York$383K
Alexander ShtilbansNew York$374K
Andrew LassmanNew York$359K
Brian ApatoffNew York$295K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →